Cryo Cell International (CCEL) Long-Term Deferred Tax (2010 - 2026)

Cryo Cell International has disclosed Long-Term Deferred Tax across 15 years of filings, most recently posting $23.6 million for Q1 2026.

• In Q1 2026, Long-Term Deferred Tax rose 13.55% year-over-year to $23.6 million; the TTM figure through Feb 2026 stood at $23.6 million (up 13.55% YoY), while the FY2025 annual figure was $23.6 million, up 13.55% from the prior year.
• Long-Term Deferred Tax was little changed at $23.6 million in Q1 2026, from $23.6 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for CCEL reached as high as $23.6 million in Q4 2025 and fell as low as $12.0 million in Q1 2022.
• The 5-year median for Long-Term Deferred Tax is $20.5 million (2023), against an average of $17.8 million.
• Annual changes were most pronounced in 2023 — Long-Term Deferred Tax jumped 49.12% — and 2024, when it increased 1.51%.
• A 5-year view of Long-Term Deferred Tax shows it stood at $13.7 million in 2022, then surged by 49.12% to $20.5 million in 2023, then grew by 1.51% to $20.8 million in 2024, then grew by 13.55% to $23.6 million in 2025, then changed by 0.0% to $23.6 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $23.6 million, $23.6 million, and $20.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.